Company / Shares Outstanding
Krystal Biotech, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
28.8M
FY2025
5-year range
22.2M / 28.8M
FY2021-FY2025
Trend
+2.0%
vs FY2024
Sector context
#193 of 212
Health Care
What the data says
Among 212 Health Care companies, Krystal Biotech, Inc. is in the top 9% for shares outstanding. Shares Outstanding has increased for 9 consecutive years, from 877490.00 in FY2016 to 28794000.00 in FY2025.
Based on SEC 10-K filings.
28794000.00 in FY2025 with a 5-year CAGR of +8.9%.
Increased from 25763743.00 to 28794000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 212This company 28.8M Sector average 306.7M
▼
-90.6% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 2.0% year-over-year.
- Ranks #193 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 28.8M | +2.0% |
| FY2024 | 28.2M | +9.6% |
| FY2023 | 25.8M | +1.1% |
| FY2022 | 25.5M | +14.8% |
| FY2021 | 22.2M | +18.1% |
| FY2020 | 18.8M | +18.2% |
| FY2019 | 15.9M | +41.9% |
| FY2018 | 11.2M | +109.0% |
| FY2017 | 5.4M | +510.9% |
| FY2016 | 877.5K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026